XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense is presented in the same expense line items as cash compensation paid and for the three and nine months ended September 30, 2025 and 2024 is as follows:
Three months ended September 30,Nine months ended September 30,
2025202420252024
Research and Development$99,801 $98,292 $283,438 $286,955 
General and Administrative154,597 72,884 382,350 209,458 
Total Stock-Based Compensation Expense$254,398 $171,176 $665,788 $496,413 
Schedule of Weighted Average Assumptions A summary of the Company's assumptions used in determining the fair value of the stock options granted during the nine months ended September 30, 2025 and 2024 is shown in the following table:
Nine months ended September 30,
20252024
Risk-Free Interest Rate3.97 %4.44 %
Expected Life (years)66
Expected Stock Price Volatility136.6 %140 %
Expected Dividend Yield— %— %
Schedule of Stock Option Activity
Following is a summary of stock option activity for the nine months ended September 30, 2025:
Number of
Options
Weighted- Average
Exercise Price
Weighted- Average
Remaining
Term in Years
Outstanding at December 31, 2024161,303$21.15 9.00
Granted246,885$2.93 
Expired(34)$22,645.06 
Outstanding at September 30, 2025408,154$8.24 9.01
Exercisable and vested at September 30, 2025104,359$22.39 8.12
Schedule of Restricted Stock Activity The following is a summary of restricted stock activity for the nine months ended September 30, 2025:
Number of
Units
Weighted- Average
Grant Date Fair Value
Weighted- Average
Remaining
Term in Years
Non-vested Outstanding at December 31, 202446,697$7.56 2.19
Awarded43,069$2.93 
Released(17,879)$7.37 
Non-vested Outstanding at September 30, 202571,887$4.83 2.09